Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding
Open Access
- 1 February 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 31 (2) , 358-363
- https://doi.org/10.1002/hep.510310215
Abstract
For the prevention of recurrent esophageal variceal bleeding, studies show that patients treated with transjugular intrahepatic portosystemic shunt (TIPS) have lower rebleeding rates compared with endoscopic therapy. However, TIPS is associated with higher rates of portosystemic encephalopathy and possibly higher costs. The aim of this study was to conduct a cost-effectiveness analysis comparing TIPS with endoscopic sclerotherapy and endoscopic ligation for the prevention of recurrent esophageal variceal bleeding. Data for rates of rebleeding, death, complications, and crossover from endoscopy to TIPS were obtained from the literature. Costs for procedures and hospitalizations were obtained from two medical centers. Sensitivity analyses were performed varying probabilities of key variables. The patient population consisted of a hypothetical cohort of cirrhotic patients successfully treated for esophageal variceal bleeding with endoscopic sclerotherapy who received prophylactic sclerotherapy, ligation, or TIPS over 1 year. Endoscopic patients would receive propranolol. Mortality was similar for the three groups. The number of bleeds per patient for sclerotherapy, ligation, and TIPS would be 0.39, 0.32, and 0.07, respectively. The total annual costs per patient for sclerotherapy, ligation, and TIPS were $23,459, $23,111, and $26,275, respectively. The incremental cost per bleed prevented for TIPS compared with sclerotherapy and ligation was $8,803 and $12,660, respectively. The incremental cost per bleed prevented for TIPS compared with sclerotherapy or ligation was sensitive to the cost of TIPS and the TIPS stenosis rate. Ligation had lower costs and lower recurrent bleeding rates than sclerotherapy. Compared with endoscopic therapy, TIPS leads to lower recurrent variceal bleeding rates and it is more cost effective in the short term for the prevention of recurrent esophageal variceal bleeding.Keywords
This publication has 21 references indexed in Scilit:
- Transjugular Intrahepatic Portosystemic Shunt or Sclerotherapy: Which Would You Choose?Annals of Internal Medicine, 1998
- Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trialHepatology, 1998
- Endoscopic Sclerotherapy Compared with Percutaneous Transjugular Intrahepatic Portosystemic Shunt after Initial Sclerotherapy in Patients with Acute Variceal HemorrhageAnnals of Internal Medicine, 1997
- Transjugular Intrahepatic Portosystemic Shunts Compared with Endoscopic Sclerotherapy for the Prevention of Recurrent Variceal HemorrhageAnnals of Internal Medicine, 1997
- Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varicesHepatology, 1997
- Endoscopic Ligation Compared with Sclerotherapy for Treatment of Esophageal Variceal BleedingAnnals of Internal Medicine, 1995
- A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varicesHepatology, 1995
- Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varicesThe Lancet, 1993
- Endoscopic Ligation Compared with Sclerotherapy for the Treatment of Bleeding Esophageal VaricesAnnals of Internal Medicine, 1993
- Endoscopic Sclerotherapy as Compared with Endoscopic Ligation for Bleeding Esophageal VaricesNew England Journal of Medicine, 1992